Literature DB >> 12563602

Sickle cell disease and the kidney.

Jon I Scheinman1.   

Abstract

Sickle cell disease (SCD) affects the kidney by acute mechanisms, as a form of the sickle crisis, and insidiously with renal medullary/papillary necrosis, with resulting tubular defects. Glomerular hyperperfusion and hypertrophy results in a chronic sickle cell nephropathy that results in a significant morbidity in the progression to end-stage kidney disease. Kidney transplantation offers a major advantage to survival, and should be coupled with efforts toward prevention of recurrent disease. Copyright 2003, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Year:  2003        PMID: 12563602     DOI: 10.1053/snep.2003.50006

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  9 in total

1.  Correction of murine sickle cell disease using gamma-globin lentiviral vectors to mediate high-level expression of fetal hemoglobin.

Authors:  Tamara I Pestina; Phillip W Hargrove; Dennis Jay; John T Gray; Kelli M Boyd; Derek A Persons
Journal:  Mol Ther       Date:  2008-12-02       Impact factor: 11.454

2.  Current sickle cell disease management practices in Nigeria.

Authors:  N Galadanci; B J Wudil; T M Balogun; G O Ogunrinde; A Akinsulie; F Hasan-Hanga; A S Mohammed; M O Kehinde; J A Olaniyi; I N Diaku-Akinwumi; B J Brown; S Adeleke; O E Nnodu; I Emodi; S Ahmed; A O Osegbue; N Akinola; H I O Opara; S A Adegoke; J Aneke; A D Adekile
Journal:  Int Health       Date:  2013-10-10       Impact factor: 2.473

3.  Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review.

Authors:  Jane A Little; Vicki R McGowan; Gregory J Kato; Kristine S Partovi; Jordan J Feld; Irina Maric; Sabrina Martyr; James G Taylor; Roberto F Machado; Theo Heller; Oswaldo Castro; Mark T Gladwin
Journal:  Haematologica       Date:  2006-08       Impact factor: 9.941

4.  Correction of murine hemoglobinopathies by prenatal tolerance induction and postnatal nonmyeloablative allogeneic BM transplants.

Authors:  William H Peranteau; Satoshi Hayashi; Osheiza Abdulmalik; Qiukan Chen; Aziz Merchant; Toshio Asakura; Alan W Flake
Journal:  Blood       Date:  2015-06-29       Impact factor: 22.113

5.  Sickle Cell Nephropathy and Associated Factors among Asymptomatic Children with Sickle Cell Anaemia.

Authors:  Uchenna Modestus Nnaji; Christian Chukwukere Ogoke; Henrietta Uche Okafor; Kingsley I Achigbu
Journal:  Int J Pediatr       Date:  2020-08-14

6.  Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.

Authors:  Paul Drawz; Sabarish Ayyappan; Mehdi Nouraie; Santosh Saraf; Victor Gordeuk; Thomas Hostetter; Mark T Gladwin; Jane Little
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-15       Impact factor: 8.237

7.  Degrees of kidney disease in nigerian adults with sickle-cell disease.

Authors:  John C Aneke; Adegbola O Adegoke; Anthony A Oyekunle; Patrick O Osho; Abubakra A Sanusi; Emmanuel C Okocha; Nancy C Ibeh; Norah O Akinola; Muheez A Durosinmi
Journal:  Med Princ Pract       Date:  2014-04-16       Impact factor: 1.927

Review 8.  Prevalence and Factors Associated with Acute Kidney Injury in Sub-Saharan African Adults: A Review of the Current Literature.

Authors:  Charles Kangitsi Kahindo; Olivier Mukuku; Stanis Okitotsho Wembonyama; Zacharie Kibendelwa Tsongo
Journal:  Int J Nephrol       Date:  2022-03-15

9.  Effect of sickle cell crises on glomerular filtration rate in children with sickle cell disease in Ilorin, Nigeria.

Authors:  E A Anigilaje; A Adeniyi; O T Adedoyin
Journal:  Indian J Nephrol       Date:  2013-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.